Paper21391110
Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.
Borde P and 2 others. Nat Prod Res, 2011. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Papers, record 21391110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21391110
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Antioxidants | Major topic |
| Flavonoids | Major topic |
| Hypertension | Major topic |
| Vitaceae | Major topic |
| Angiotensin II | |
| Animals | |
| Blood Pressure | |
| Catalase | |
| Desoxycorticosterone | |
| Disease Models, Animal | |
| Female | |
| Glutathione | |
| Heart Rate | |
| Oxidative Stress | |
| Rats | |
| Rats, Wistar | |
| Serotonin | |
| Sodium Chloride | |
| Superoxide Dismutase | |
| Thiobarbituric Acid Reactive Substances |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41838190 | BACH2 ameliorates cell apoptosis and autophagy as a molecular switch of BCL-2/Beclin-1 complex in myocardial infarction. | Apoptosis | 2026 | https://conductscience.org/library/papers/41838190 | PubMed |
| 41228490 | Natural Sweetness and Bioactivity: The Cardiovascular Promise of Fruits. | Nutrients | 2025 | https://conductscience.org/library/papers/41228490 | PubMed |
| 40739693 | Unveiling the Health Potential of Myricetin: Bio-accessibility, Safety Considerations, and Therapeutic Mechanisms. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/40739693 | PubMed |
| 39076470 | Increased Secreted Frizzled-Related Protein 2 in Hypertension-Induced Left Ventricular Remodeling. | Rev Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39076470 | PubMed |
| 38167793 | Myricetin May Improve Cardiac Dysfunction Possibly Through Regulating Blood Pressure and Cellular Stress Molecules in High-Fructose-Fed Rats. | Anatol J Cardiol | 2024 | https://conductscience.org/library/papers/38167793 | PubMed |
| 36339605 | Grape exosome-like nanoparticles: A potential therapeutic strategy for vascular calcification. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339605 | PubMed |
| 36091787 | Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36091787 | PubMed |
| 35281911 | A Comparative Study of the Antihypertensive and Cardioprotective Potentials of Hot and Cold Aqueous Extracts of Hibiscus sabdariffa L. in Relation to Their Metabolic Profiles. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35281911 | PubMed |
| 34858028 | Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action. | Vasc Health Risk Manag | 2021 | https://conductscience.org/library/papers/34858028 | PubMed |
| 34765268 | Recent advances in research on vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds. | J Pharm Anal | 2021 | https://conductscience.org/library/papers/34765268 | PubMed |
| 33946951 | Interactions between Phosphatidylcholine and Kaempferol or Myristicin: Langmuir Monolayers and Microelectrophoretic Studies. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33946951 | PubMed |
| 32738903 | Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32738903 | PubMed |
| 31885808 | Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31885808 | PubMed |
| 31309069 | Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna's Canon of Medicine. | Avicenna J Phytomed | 2019 | https://conductscience.org/library/papers/31309069 | PubMed |
| 30825074 | Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes. | Eur J Drug Metab Pharmacokinet | 2019 | https://conductscience.org/library/papers/30825074 | PubMed |
| 26891321 | Myricetin: A Dietary Molecule with Diverse Biological Activities. | Nutrients | 2016 | https://conductscience.org/library/papers/26891321 | PubMed |
| 25234650 | Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension. | Mol Biol Rep | 2015 | https://conductscience.org/library/papers/25234650 | PubMed |
| 22526544 | Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. | Psychopharmacology (Berl) | 2012 | https://conductscience.org/library/papers/22526544 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21391110
GET https://conductscience.org/api/papers/v1/21391110/authors